Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chronic Disease Sufferers To Benefit From New ‘At Home’ Diagnostic Device

22.07.2004


People who suffer from chronic diseases, including high blood pressure, diabetes, asthma and heart problems should benefit from a new remote, home care monitoring system that could also bring an end to overcrowded waiting rooms.



With project partners in Estonia, Latvia and the UK facing research costs of over €2 million, the development of Doc@HOME® was made possible with the help of a grant of €1.1 million from the Information Society Technology (IST) Programme of the European Union’s Framework Programme. It is now set to improve the quality of life of thousands of people, including the elderly and disabled, by freeing up time currently spent on doctors and hospital visits. This in turn will help ease the pressure on the family doctor.

Low cost and easy to use, Doc@HOME® gives the patient a sense of control over their condition and allows their medical carers to stay ahead of the disease. It also provides education about the disease and its risk factors, and supports lifestyle modification strategies that need to be introduced to help manage the condition.


Adrian Flowerday, managing director of the UK partner Docobo UK, is confident the new system will be welcomed around the world, saying: "The World Health Organisation sees Chronic Disease as being the greatest challenge to the healthcare systems and populations of the world this century. The Doc@HOME® service provides a low cost, home based chronic disease management solution to help the national healthcare organisations address these challenges. Patients with chronic diseases such as hypertension, Chronic Obstructive Pulmonary Disease (COPD) and diabetes will be enabled to monitor and control their own condition, confident in the knowledge that the healthcare systems are monitoring their progress."

Peter Walters, UK National Contact Point for IST within the EU’s 6th Framework Programme, believes that the Doc@HOME® project is a prime example of the major contribution EU funding has in the development of information and communications technology: “This project shows how, with the right financial support, information technology can have a much wider role to play in our futures. Without support from the EU’s Framework Programme this project may not have been possible.”

“The Framework Programmes are the EU’s main vehicle for support of leading edge, internationally collaborative R&D. The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the €17.5bn available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

With over two billion people in the world suffering with Hypertension and Diabetes, conservative forecasts indicate that Doc@HOME® will have around 300,000 users by 2007. Potential customers for the system include both public and private healthcare organisations, health conscious consumers, insurance companies and occupational health departments within large employers, and the manufacturers have already identified a potential sales revenue of £70 million.

The system is being trailed with two NHS organisations and patients involved in the trials are pleased with the service. “I would like to control my blood pressure without having to become dependant upon medication,” says businessman Ian MacDonald of Glasgow. “The Doc@HOME® service helped me to appreciate and control my blood pressure. I had to travel a lot during the period of the trial and this handy, portable unit made it easy to monitor my blood pressure and adjust my lifestyle accordingly. Anything that enables people to have better control of their health must be a good thing.”

Fellow patient John Millar, also from Glasgow, added: “It will be particularly helpful to people just starting on medication as it also reminds you when to take it. I would also recommend it to my doctor as I believe that any system that helps reduce the pressure on him has got to be a great concept.”

The device includes basic ECG capability for arrhythmia and the detection of other long terms trends. It can also integrate with other pieces of medical equipment – blood pressure, weight, glucose measuring devices etc - to collect, store and forward the entered data.

Already the system is being adapted for patients who need regular monitoring for a number of medical conditions, including: Chronic Heart Failure (CHF), Asthma, Diabetes, Post-Stroke care and surveillance, Chronic Obstructive Pulmonary Disease, Chronic respiratory disease.

The system is also expandable to more general interest groups like weight control and personal fitness programs, and reduces the overall cost of patient care, bringing a rage of benefits to the patient, their family and their doctor.

Patient benefits include:

A more active role in the health support process.
More control over the symptoms of illness and therefore more freedom of life.
Improved chances to continue regular working by freeing up the time spent on regular visits to medical institutions.
The sense of care immediacy.

Benefits to the doctor include:

A continuous and adequate overview of the health status of the patient in their actual living environment.
Easier management of a large number of patients.
A reduction of the misplaced time and expenditures.

Family members also benefit by having a better overview of the health status of their relative, and the pressure on hospitals will be eased thanks to a reduction of admissions of patients with chronic conditions for routine examination.

The system is built around a low-cost device (the projected end user cost is around 200 Euros) specially constructed for the purpose of long-term trouble free data collection, with design features considering the needs of the typical home care population (elderly people, disabled people etc).

Dave Sanders | alfa
Further information:
http://www.glasgows.co.uk

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>